Education

Satellite Meetings

Six companies are hosting satellite meetings in conjunction with the ASAM Annual Conference. Please take a look at the events listed below.

Note: The events are not part of the official ASAM Annual Conference as planned by its Program Committee.  Attendance is optional, and in some cases, there is limited seating. 

Event Information:

Triple E for HCV: Engagement, Education and Eradication of HCV among Patients with Substance Use Disorders

SPONSORED BY: CHRONIC LIVER DISEASE FOUNDATION

Friday, April 15, 2016
8:00 pm - 9:30 pm
Hilton Baltimore, Holiday Ballroom 4-6, Second Floor

As the treatment for hepatitis C virus (HCV) continues to advance at an extremely rapid pace with new discoveries and developments over recent years and the rising numbers of HCV infections within the people who inject drugs (PWID) population, a significant educational need exists for health care professionals who are involved in the management of persons with substance use disorders. With safe and highly efficacious treatments now available for HCV, these health care professionals require a detailed understanding of the importance of screening, diagnosis and treatment. This symposium will highlight and reinforce the recognition of, methods for diagnosing, and the management of HCV. The symposium will provide abundant opportunities for audience input, faculty presentation and panel discussion regarding the best treatment strategies for a given patient. For More Information Please Email: info@chronicliverdisease.org.

Faculty:
Dr. Lawrence S. Brown, Jr., START Treatment & Recovery Center, Brooklyn, NY 
Dr. Vinod Rustgi, Thomas E. Starzl Transplantation Institute, Pittsburgh, PA
Andrew Reynolds, Project Inform, San Francisco, CA


A Patient's Journey Through OUD Treatment: Can We Define When It Ends?

SPONSORED BY: INDIVIOR, INC.

Friday, April 15, 2016
8:00 pm–8:30 pm - Registration and Reception
8:30 pm–9:30 pm - Symposium
Hilton Baltimore, Key Ballroom 9-10, Second Floor

A Patient's Journey Through OUD Treatment: Can We Define When It Ends? will focus on the chronic, relapsing nature of opioid addiction and will include a brief overview of the structural and functional changes that occur in the brains of afflicted individuals.  Experts in the field will explore concepts of treatment success and recovery, and discuss the continuum of care for OUD, for example, the importance of individualized treatments, incremental successful outcomes, and patient-centric goals for recovery.  Strategies to help improve the likelihood of successful recovery outcomes will address treatment retention, medication-assisted treatment, and behavioral/psychosocial support. The value of a stigma-free approach to each patient’s treatment plan will be emphasized.  Interactive questioning will be utilized to enhance attendee engagement. TO PRE-REGISTER: please email OUDReg@complete-mc.com; please include your name, title, and affiliation/institution. When you pre-register, you will also be agreeing to receive a short pre-meeting survey of attendees via email auto-reply.  We hope you will complete the pre-meeting survey; you will have an opportunity to opt out from any further informational email communications from CMC and/or Indivior relevant to Opioid Use Disorder and this program at any time.  

Faculty:
Adam Bisaga, MD, Professor of Psychiatry at CUMC, Columbia University College of Physicians and Surgeons, New York, NY
George E. Woody, MD, Professor, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA


The Importance of an Opioid Emergency Plan: Amplifying the Voice for Take-Home Naloxone

SPONSORED BY: KALEO

Saturday, April 16, 2016
5:30 pm - Registration & Dinner
6:00 pm - Program
Hilton Baltimore, Key Ballroom 8, Second Floor 

Opioid-related deaths, from both heroin and prescription opioids, have reached epidemic levels in the UnitedStates, with more people dying in 2014 than during any previous year on record. Patients with opioid use disorder (OUD) are at risk for relapse and overdose throughout the continuum of care. Seconds count with opioid overdose emergencies, and without intervention hypoxia may result in brain injury in as little as 4 minutes. However, the average emergency medical services (EMS) response time is approximately 9.4 minutes. Most opioid overdose emergencies occur in the home and are witnessed by friends or family who may be in the best position to intervene quickly prior to EMS arrival. Injectable naloxone has been a proven treatment for more than 40 years to reverse opioid-induced respiratory depression. It is traditionally administered in hospitals, by EMS, and in the harm reduction community. Many state, national, and international government and professional organizations are calling for naloxone to be readily accessible to individuals likely to witness an opioid overdose emergency. American Society of Addiction Medicine practice guidelines recommend OUD patients and families be given prescriptions and trained on the use of naloxone.

During this symposium, the faculty will present the epidemiology of opioid overdose emergencies, provide guidance on how to identify and communicate with at-risk patients, and offer strategies to help patients develop an opioid overdose emergency plan.

Registration Link: https://www.surveymonkey.com/r/kaleoASAM2016.

Moderator
Eric S. Edwards, MD, PhD, Chief Medical Officer and Vice President Research & Development, Kaleo, Inc., Richmond, Virginia

Faculty
Michael P. Frost MD, FACP, FASAM, Medical Director, Eagleville Hospital, Eagleville, Pennsylvania
Stuart Gitlow, MD, MPH, MBA, Immediate Past President & AMA Delegate, American Society of Addiction Medicine; Executive Director, Annenberg Physician Training Program in Addictive Disease,Icahn School of Medicine at Mount Sinai, New York, NY.


HCV Care: Exploring the Link in Addiction Medicine

SPONSORED BY: GILEAD SCIENCES, INC.

Saturday, April 16, 2016
5:30 pm – 7:00 pm
Hilton Baltimore, Poe AB, Second Floor

Please RSVP to Michelle Mancuso via e-mail at Michelle.Mancuso@gilead.com by Wednesday, April 13, 2016.

Faculty:
Tony Martinez, MD, Associate Clinical Professor of Medicine, University of Buffalo; Medical Director, Hepatology, Erie County Medical Center, Buffalo, NY


Luminous Health Lab (formerly Southwest Laboratories) – Clarity. Insight. Results

SPONSORED BY: LUMINOUS HEALTH LABORATORIES

Saturday, April 16, 2016
5:30 pm – 7:00 pm
Hilton Baltimore, Latrobe, First Floor

Please join Luminous Health Laboratory for an overview of lab services including clinical application and standard protocol for the following tests:

  • LC/MS Definitive testing
  • Pharmacogenetic Testing
  • Blood Testing
  • Women’s and Men’s Wellness
  • Advanced Lipids
  • Pre and Post OP testing

Faculty:
Dr. Gabriel Rodriguez will discuss his use of the above tests and the related advantages to patient treatment. We will also discuss an exciting opportunity for physicians to join our team. More information will be provided on this specific topic during our meeting.


The Addiction Medicine Foundation Next Generation Awards Reception

Saturday, April 16, 2016
5:30 pm – 7:00 pm
Hilton Baltimore, Ruth, First Floor

All conference attendees are welcome as The Addiction Medicine Foundation presents the 2016-17 Next Generation Award for Adolescent Substance Use Prevention to six emerging leaders in the field of addiction medicine. Please join your colleagues to celebrate the 2016-17 Awardees and learn more about their plans to address the prevention of and early intervention for substance use among adolescents and young adults as part of their addiction medicine fellowship training. Also meet the current class of 2015-16 Next Generation Fellows who will present posters on their work. After the presentations, enjoy an opportunity to network and chat over refreshments with those who will help shape the future of addiction medicine. For additional information, please contact Andy Danzo at adanzo@buffalo.edu.